- Home
- CLW vs FENC Comparison
CLW vs FENC Comparison
Compare CLW & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- FENC
- Stock Information
- Founded
- CLW 2005
- FENC 1996
- Country
- CLW United States
- FENC United States
- Employees
- CLW N/A
- FENC N/A
- Industry
- CLW Paper
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLW Basic Materials
- FENC Health Care
- Exchange
- CLW Nasdaq
- FENC Nasdaq
- Market Cap
- CLW 293.0M
- FENC 234.9M
- IPO Year
- CLW N/A
- FENC 2001
- Fundamental
- Price
- CLW $17.41
- FENC $7.87
- Analyst Decision
- CLW Strong Buy
- FENC Strong Buy
- Analyst Count
- CLW 2
- FENC 2
- Target Price
- CLW $30.00
- FENC $13.50
- AVG Volume (30 Days)
- CLW 211.8K
- FENC 149.4K
- Earning Date
- CLW 10-28-2025
- FENC 11-13-2025
- Dividend Yield
- CLW N/A
- FENC N/A
- EPS Growth
- CLW 875.72
- FENC N/A
- EPS
- CLW 8.63
- FENC N/A
- Revenue
- CLW $1,556,100,000.00
- FENC $38,790,000.00
- Revenue This Year
- CLW $13.91
- FENC N/A
- Revenue Next Year
- CLW N/A
- FENC $64.79
- P/E Ratio
- CLW $2.00
- FENC N/A
- Revenue Growth
- CLW 23.00
- FENC N/A
- 52 Week Low
- CLW $16.53
- FENC $4.60
- 52 Week High
- CLW $33.57
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- CLW 38.35
- FENC 42.10
- Support Level
- CLW $17.68
- FENC $7.53
- Resistance Level
- CLW $18.84
- FENC $9.00
- Average True Range (ATR)
- CLW 0.68
- FENC 0.55
- MACD
- CLW -0.06
- FENC 0.01
- Stochastic Oscillator
- CLW 33.96
- FENC 17.69
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.